NeoDynamics – Presentation of Q3 interim report 2023

Meet and ask questions to CFO Aaron Wong from NeoDynamics on 29 November 2023 at 09:30 when he presents the Q3 numbers and gives an update on the development in the US.

NeoDynamics AB (publ) is a Swedish medical technology company dedicated to advancing the diagnostics and treatment of cancer. The company has created an innovative biopsy system called NeoNavia®. This biopsy system builds on a patented pulse technology based on research at the Karolinska Institutet in Sweden. The innovative pulse biopsy system is designed to offer clinicians and patients reliable tissue sampling with high tissue yield for correct diagnosis and individualized treatment. NeoNavia has been launched in the Swedish, German, and British markets. NeoDynamics is listed on Nasdaq’s First North Growth Market in Stockholm.

Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a DigitalIR/Corporate Visibility agreement. Claus Thestrup 10:06 AM CEST – 02/10/2023. (Updated 11.46 28/11/2023)